European Commission approves Pfizer’s Cibinqo to treat adults with moderate-to-severe atopic…
Cibinqo is a once-daily oral treatment with proven efficacy demonstrated in a large-scale clinical trial programme
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.